Hodgkin’s vs. non-Hodgkin’s lymphoma: How they differ

Quick heads-up: This article is for education, not a diagnosis. If you (or someone you love) has symptoms like persistent swollen lymph nodes, unexplained fevers, drenching night sweats, or unintentional weight loss, it’s worth getting checked by a healthcare professional.

Lymphoma is cancer that starts in lymphocyteswhite blood cells that help run your immune system. Think of lymphocytes as your body’s “neighborhood watch,” patrolling lymph nodes, spleen, bone marrow, and other tissues for troublemakers. When they go rogue and start multiplying uncontrollably, lymphoma can form.

Here’s where it gets a little confusing: there are two big families of lymphomaHodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). They can look similar from the outside (swollen lymph nodes, fatigue, “B symptoms”), but inside the microscopeand in how they behave and respond to treatmentthey’re meaningfully different.

A fast, practical takeaway

• Hodgkin lymphoma is defined by the presence of Reed–Sternberg cells (or related variants), and it often spreads through lymph nodes in a more orderly/contiguous pattern.
• Non-Hodgkin lymphoma is an umbrella category for many different subtypes (70+ is a common estimate), often with more variable behavior and a higher chance of starting or spreading outside lymph nodes (extranodal disease).
• Both are treatable; “best” treatment depends on subtype, stage, and personal factors like age, overall health, and goals.

What exactly is the difference?

Doctors separate HL and NHL based primarily on what the cancer cells look like and which biomarkers they carry. The most famous difference is microscopic:

1) The “signature cell”: Reed–Sternberg cells

Classic Hodgkin lymphoma is marked by abnormal cells called Reed–Sternberg cells. Interestingly, those cells can be a small fraction of the tumor areasurrounded by lots of normal immune cells that contribute to the swelling in lymph nodes. In other words, the “party” looks crowded, but only a few guests are actually causing chaos.

In non-Hodgkin lymphoma, doctors typically do not see Reed–Sternberg cells. Instead, they find other abnormal B cells, T cells, or NK cells, depending on the subtype.

2) How they tend to spread

Hodgkin lymphoma more often spreads through lymph nodes in a relatively predictable, stepwise wayoften from one lymph node group to adjacent groups. Non-Hodgkin lymphoma can spread in a less predictable pattern and is more likely to involve organs or tissues outside lymph nodes (like the stomach, skin, brain, or bone marrow) depending on subtype.

3) How many “types” you’re dealing with

Hodgkin lymphoma has fewer main categories. The big split is:

• Classic Hodgkin lymphoma (cHL) (the majority of cases)
• Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) (a smaller, distinct group)

Non-Hodgkin lymphoma is the opposite: it’s a huge category with many subtypes, often grouped as:

• B-cell lymphomas (the most common overall)
• T-cell and NK-cell lymphomas

Side-by-side comparison (the “at a glance” table)

Symptoms: why HL and NHL can feel the same at first

Both HL and NHL can cause similar symptoms because they affect the same immune/lymph system “real estate.” Many people first notice:

• Painless swollen lymph nodes (neck, underarm, groin)
• Fatigue that doesn’t match your sleep schedule
• Fever without a clear infection
• Drenching night sweats
• Unintentional weight loss
• Itching (sometimes)

Those fever/night sweats/weight loss symptoms are often called “B symptoms”, and they can matter for staging and treatment planning.

A couple of realistic examples

Example A: A 20-something notices a painless lump in the neck that doesn’t go away after a few weeks, plus night sweats. Imaging suggests enlarged lymph nodes. A biopsy shows Reed–Sternberg cells → that points toward classic Hodgkin lymphoma.

Example B: A 60-something develops rapidly enlarging lymph nodes and new abdominal fullness. Biopsy shows a fast-growing B-cell lymphoma pattern → that may be diffuse large B-cell lymphoma (DLBCL), a common non-Hodgkin subtype.

Same “swollen nodes” headline. Totally different story underneath.

Risk factors and causes: what we know (and what we don’t)

Let’s be honest: most people want a clean answer like “It was this one thing.” Lymphoma doesn’t usually work that way. For both HL and NHL, many patients have no obvious risk factor. Still, research has identified patterns that can raise risk.

Shared risk themes

• Immune system issues: immune suppression (from certain medicines, organ transplant, some health conditions) can increase risk for multiple lymphoma types.
• Some infections: certain viruses and chronic infections are linked with some lymphomas.
• Family history: having a close relative with lymphoma can slightly raise risk, though most cases are not inherited.

Epstein–Barr virus (EBV): a known link

EBV (the virus best known for causing mono) has associations with several cancers, including Hodgkin disease and some forms of non-Hodgkin lymphoma. Not everyone with EBV gets lymphomafar from itbut the connection is well established in medical literature.

Non-Hodgkin lymphoma has subtype-specific triggers

One reason NHL is so complex: some subtypes have very specific links. For example, certain MALT lymphomas can be connected to chronic infections/inflammation in a particular tissue, and some lymphomas occur more often with chronic immune stimulation. That doesn’t mean “infection causes lymphoma” in a simple wayjust that biology can be opportunistic when the immune system is under long-term strain.

Diagnosis: the test that matters most

If there’s one point to tattoo on the forehead of the internet, it’s this: lymphoma diagnosis requires tissue. Blood tests and scans can suggest lymphoma, but they usually can’t confirm the exact type.

Step 1: History, exam, and basic labs

Clinicians ask about symptoms (including B symptoms), examine lymph node areas, and often order labs to check blood counts and organ function. These tests help assess overall health and guide next steps, but they’re not the final word.

Step 2: Imaging (often CT and/or PET/CT)

Imaging can show where disease might be and how extensive it looks. PET/CT is commonly used in many lymphoma settings because it can help evaluate activity and response to treatment.

Step 3: Biopsy (the decider)

A biopsy lets pathologists examine cell shape, growth pattern, and biomarkers. This is where HL vs NHL gets sorted outespecially through identifying (or not identifying) Reed–Sternberg cells and using immunophenotyping markers.

Step 4: Staging and risk scoring

Staging describes how far lymphoma has spread (lymph node regions, organs, bone marrow, etc.). Many treatment plans use stage plus other factors (bulk of disease, symptoms, lab values, and subtype-specific risk tools) to personalize therapy.

Treatment differences: same goal, different playbooks

In both HL and NHL, treatment is chosen based on a mix of: subtype, stage, tumor burden, symptoms, and patient factors (age, heart health, fertility goals, other conditions). But the “default” regimens and strategies tend to differ.

How Hodgkin lymphoma is often treated

For many patients, especially with classic HL, treatment commonly involves:

• Chemotherapy (often a defined combination regimen), sometimes followed by
• Radiation therapy to involved areas depending on stage/risk and response

Modern HL care may also include targeted therapy (such as antibody-drug conjugates in certain situations) and immunotherapy (like checkpoint inhibitors) particularly in relapsed or refractory disease. For some cases that return after initial treatment, doctors may consider high-dose therapy with stem cell transplant if appropriate.

How non-Hodgkin lymphoma is often treated

NHL isn’t one diseaseit’s a whole library. Treatment ranges from “monitor carefully” to “treat urgently,” depending on the subtype.

Indolent (slow-growing) NHL

Some slow-growing lymphomas may not need immediate therapy if they’re not causing problems. This approach is often called active surveillance or “watch and wait.” When treatment is needed, options can include antibody therapy, chemo-immunotherapy, radiation for localized disease, and targeted drugs.

Aggressive (fast-growing) NHL

Many aggressive B-cell lymphomas are treated with combination therapy. A classic example is DLBCL, often treated with chemo plus an antibody therapy (commonly known by regimens like R-CHOP). Treatment planning may also include follow-up imaging to evaluate response, and for higher-risk or relapsed cases, additional strategies (including transplant or cellular therapies such as CAR T-cell therapy) may be considered.

Outlook and survivorship: why “type” matters so much

People often ask, “Which one is worse?” It’s an understandable questionbut it’s also a trick question, because it depends on subtype and situation.

Hodgkin lymphoma is frequently described as one of the more treatable cancers overall, and many patients are curedespecially when diagnosed and treated promptly.

Non-Hodgkin lymphoma spans a wide range: some subtypes are highly curable; others behave more like chronic illnesses with periods of remission and relapse; and some are rare and challenging. The good news is that treatment options have expanded rapidly in recent years, including targeted therapies and immunotherapies.

Life after treatment

Survivorship isn’t just “the end.” It’s a phase with its own checklist: follow-up visits, monitoring for late effects (which can depend on the treatments used), vaccinations and infection prevention planning, emotional recovery, and rebuilding routines. Many cancer centers and advocacy organizations encourage survivorship care planning so patients know what to watch for and when.

Questions to ask your care team (so you leave with answers, not just a pamphlet)

• What exact lymphoma type and subtype do I have, and how certain is the diagnosis?
• What stage is it, and what does that mean for my prognosis and treatment plan?
• Is my lymphoma considered indolent or aggressive?
• What treatment options are recommended for my situation, and why?
• What side effects should I expect short-term and long-term?
• Will treatment affect fertility, and should I consider fertility preservation?
• How will we measure responsePET/CT, CT, labs, symptoms?
• Should I consider a clinical trial?
• What support services are available (nutrition, mental health, financial counseling, support groups)?

Real-life experiences: what people often describe (and why it matters)

Note: Experiences vary widely. Two people with the “same” lymphoma diagnosis can have very different journeys depending on subtype, stage, treatment choices, side effects, support systems, and plain old biology. Still, patterns show up again and again in patient storiesand they can help you feel less blindsided.

1) The “I thought it was nothing” phase. A lot of people describe noticing a lump in the neck or underarm and assuming it’s a lingering infection. That’s especially common because swollen lymph nodes really do happen with colds and sore throats. The difference is persistence: nodes that don’t shrink over weeks (or keep growing) often lead to more testing. Many patients say the emotional whiplash is intenseone day you’re googling “why is my lymph node swollen,” and the next you’re hearing words like “biopsy” and “oncology.”

2) The waiting is its own side effect. The period between scans, biopsy, and results can feel longer than the entire semester of your hardest class. Patients often describe this as the most anxiety-heavy chapterbecause your imagination fills in every blank. Practical coping strategies people mention include bringing a friend to appointments, writing questions in advance, and asking the care team for a clear timeline (“When will results be back?” “Who will call me?”).

3) “Hodgkin” can come with hopeand complicated feelings. Many people with Hodgkin lymphoma hear that it’s “very treatable” and feel a mix of relief and guilt (because cancer is still cancer). Some describe pressure to “stay positive,” even while they’re scared. The more helpful framing patients mention is: hopeful doesn’t mean easy. Treatment can still be exhausting. It’s okay to be optimistic and overwhelmed in the same afternoon.

4) Non-Hodgkin experiences can be wildly different depending on subtype. Some patients with indolent NHL talk about the mental challenge of active surveillanceespecially explaining to friends and family why they’re “not treating cancer right away.” Others with aggressive NHL describe a fast-moving start: diagnosis, staging, treatment planning, and chemotherapy can happen quickly because the cancer can grow quickly. People often say learning the exact subtype changed everythingsuddenly they understood why the plan was urgent (or why it was reasonable to monitor).

5) Chemo is a schedule… and a lifestyle. Patients often describe treatment in cycles: “good days” and “recovery days.” Common themes include managing fatigue, protecting sleep, staying hydrated, and accepting help. Many also mention that side effects are not one-size-fits-all: one person breezes through nausea but struggles with fatigue; another feels the opposite. The most repeated advice from experienced patients is practical, not poetic: keep a symptom log, report side effects early, and don’t “tough it out” when supportive medications or dose adjustments can help.

6) Support systems matter more than people expect. In patient stories, the MVPs are often not dramatic momentsit’s the friend who drives you, the coworker who covers a shift, the family member who sits quietly during infusion, or the online support group that answers weird questions at 2 a.m. Many people also describe therapy or counseling as a game-changer, especially for scan anxiety, body changes, and the identity shift that can come with a cancer diagnosis.

7) The finish line is not always a confetti moment. After treatment, some people feel relief; others feel oddly untethered. “Now what?” is common. Follow-up scans can trigger anxiety, and rebuilding stamina can take time. Survivors often describe success as small milestones: walking farther, returning to hobbies, going a week without thinking about cancer every hour. It’s gradualand that’s normal.

If you’re reading this because lymphoma is part of your life right now: you don’t need to become a medical encyclopedia overnight. But knowing whether it’s Hodgkin vs. non-Hodgkinand which subtypegives you a map. And maps are powerful when the road feels unfamiliar.

SEO Tags